₹ 1,403.80
-2.00 (-0.14%)
C
Cipla
₹ 1,403.80
Cipla EPS Summary (consolidated)
The latest quarterly EPS of Cipla as of Q2 Sep 2026 stands at ₹10.86. This is a 11.16% growth quarter on quarter and 35.09% fall same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹11.58. It missed the estimate by ₹0.71. For the FY2026 the EPS of Cipla stands at ₹48.03. This is a 26.44% fall compared with FY2025.
Cipla EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

